Skip to content

Prevalence of migraine headache in patients with allergic rhinitis

Prevalence of migraine headache in patients with allergic rhinitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/08/003901
Enrollment
100
Registered
2013-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- with allergic rhinitis

Interventions

None listed

Sponsors

father muller medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) ages 18-65 years; (2) ability to give informed consent; (3) a confirmed diagnosis of allergic rhinitis.

Exclusion criteria

Exclusion criteria: (1) past history of secondary headache disorders such as a brain aneurysm or brain tumor; (2) significant chronic medical illnesses such as malignancy, chronic renal failure, tuberculosis, lupus, rheumatoid arthritis,sarcoidosis, hypereosinophilic syndrome, Wegenerâ??granulomatosis, Churg-Strauss vasculitis, and polyarteritis nodosum; (3) pregnancy.

Design outcomes

Primary

MeasureTime frame
prevalence of migraine among allergic rhinitis patients was 73.Prevalence of migraine in patients with allergic rhinitis is higher in females compared to males.Majority patients were in the age group of 18 to 28 years.Patients with higher levels of Ig E had more severe headaches compared to those with lower levels of Ig E.Patients with higher levels of Ig E required a longer duration of treatment compared to those with lower levels of IgE Timepoint: Single point when patient presents to opd Prevalence is calculated when target of 100 patients is reached

Secondary

MeasureTime frame
treatment of migraine is effective Serum IgE levels have significant impact on severity of headaches in migraineTimepoint: once the target of 100 patients is achieved

Countries

India

Contacts

Public Contactdavid rosario

father muller medical college

georgepinto27@yahoo.co.in9844021214

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026